For example, miR-520c-3p was reported to negatively modulate epithelial-mesenchymal transition (EMT) via targeting Interleukin-8 (IL-8) to hamper BC cell malignant progression (Tang et al., 2017). The gene discussed is CXCL8; the disease is breast cancer.